欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/0364/002
药品名称
Lisidoc 5 mg Tabletten
活性成分
lisinopril dihydrate 5.44 mg
剂型
Tablet
上市许可持有人
Arrow Generics Limited 7 Cavendish Square GB-W1G 0PE London
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
许可日期
2002/09/08
最近更新日期
2015/02/12
药物ATC编码
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09A ACE INHIBITORS, PLAIN
C09AA ACE inhibitors, plain
C09AA03 lisinopril
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Article 4.8(a)(iii), first paragraph
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
common-pl-lisinopril-combined-tabs-v30
Date of last change:2012/10/19
Final SPC
|
common-spc-lisinopril-combined-tabs-v030-tracked
Date of last change:2012/10/19
Final SPC
|
common-pl-lisinopril-combined-tabs-v30-tracked
Date of last change:2012/10/19
Final SPC
|
common-spc-lisinopril-combined-tabs-v030
Date of last change:2012/10/19
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase